Acadian Asset Management’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding RGNX
RG
Acadian Asset Management's RGNX Position: Q2 2026 in Review
Acadian Asset Management sold out of Regenxbio (RGNX) in Q2 2026, closing a stake of 3,233 shares — an estimated $27K sold.
Acadian Asset Management first reported a position in RGNX in Q1 2017 and held it in 15 quarters. The position peaked at $6.23M in Q1 2019. 165 funds tracked by Wall St. Rank hold RGNX as of Q2 2026.
- Acadian Asset Management reported no remaining Regenxbio position as of Q2 2026 after selling out during the quarter.
- Acadian Asset Management sold 3,233 Regenxbio shares in Q2 2026, an estimated $27K.
- Acadian Asset Management first reported a position in Regenxbio in Q1 2017 and held it in 15 quarters.
- Acadian Asset Management's Regenxbio position peaked at $6.23M in Q1 2019.
- 165 funds tracked by Wall St. Rank held Regenxbio as of Q2 2026.
Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.